News|Articles|January 28, 2026
Striking a Balance Between Speed and Quality to Deliver Next-Generation Therapeutics
Author(s)FUJIFILM Biotechnologies
Discover how a robust platform enables fast, high-quality bispecific antibody production by optimizing gene ratios, CLD, and analytics for purity and yield.
Related Content
Trending on Pharmaceutical Technology
1
PharmTech Weekly Roundup—June 5, 2026
2
A Pharma Manufacturing Blueprint from Delaware’s Innovation Vision
3
EMA Collaborates with African Regulators on Ebola Treatments
4
Renewing Prosaic Generics for Cancer Treatment
5